Unlocking the Black Box: Matinas BioPharma Hldgs Reveals Q4 2023 Earnings Report

Published On: March 27, 2024 11:07 pm

MTNB stock - MTNB Stock Earnings: Matinas BioPharma Hldgs Reported Results for Q4 2023

Source: iQoncept / Shutterstock

Matinas BioPharma Hldgs (NYSEMKT:MTNB) has pulled back the curtain on its financial performance for the final quarter of 2023.

Matinas BioPharma Hldgs showcased earnings per share of -3 cents.
The company opted not to disclose any revenue figures for the quarter in question.

InvestorPlace Earnings utilizes data from TradeSmith to streamline coverage of quarterly earnings reports. By distilling critical takeaways such as earnings per share, revenue, and comparative analysis against analyst forecasts, we swiftly furnish our readers with the most recent data. These articles are generated autonomously without any human intervention, ensuring prompt dissemination of pertinent financial insights. For any feedback or corrections, kindly reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/mtnb-stock-earnings-matinas-biopharma-hldgs-for-q4-of-2023/.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.